2023_Novozymes' and Chr. Hansen's shareholders approve combination
Kurs
+0,23%
Likviditet
96,1 MDKK
Kalender
| Tid* | ||
| 2025-02-06 | 08:30 | Bokslutskommuniké 2024 |
| 2024-11-06 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-15 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2023-11-22 | - | Årsstämma |
| 2023-10-13 | - | X-dag bonusutdelning CHR 7.72 |
| 2023-10-12 | - | Bokslutskommuniké 2023 |
| 2023-07-06 | - | Kvartalsrapport 2023-Q3 |
| 2023-04-13 | - | Kvartalsrapport 2023-Q2 |
| 2023-03-30 | - | Extra Bolagsstämma 2023 |
| 2023-01-12 | - | Kvartalsrapport 2023-Q1 |
| 2022-11-24 | - | X-dag ordinarie utdelning CHR 7.04 DKK |
| 2022-11-23 | - | Årsstämma |
| 2022-10-12 | - | Bokslutskommuniké 2022 |
| 2022-07-07 | - | Kvartalsrapport 2022-Q3 |
| 2022-04-06 | - | Kvartalsrapport 2022-Q2 |
| 2022-01-13 | - | Kvartalsrapport 2022-Q1 |
| 2021-11-25 | - | X-dag ordinarie utdelning CHR 6.54 DKK |
| 2021-11-24 | - | Årsstämma |
| 2021-10-14 | - | Bokslutskommuniké 2021 |
| 2021-07-08 | - | Kvartalsrapport 2021-Q3 |
| 2021-05-18 | - | X-dag bonusutdelning CHR 6.54 |
| 2021-04-15 | - | Kvartalsrapport 2021-Q2 |
| 2021-01-14 | - | Kvartalsrapport 2021-Q1 |
| 2020-11-26 | - | X-dag ordinarie utdelning CHR 0.00 DKK |
| 2020-11-25 | - | Årsstämma |
| 2020-10-08 | - | Bokslutskommuniké 2020 |
| 2020-07-02 | - | Kvartalsrapport 2020-Q3 |
| 2020-04-16 | - | Kvartalsrapport 2020-Q2 |
| 2020-01-15 | - | Kvartalsrapport 2020-Q1 |
| 2019-11-28 | - | X-dag ordinarie utdelning CHR 7.07 DKK |
| 2019-11-27 | - | Årsstämma |
| 2019-10-10 | - | Bokslutskommuniké 2019 |
| 2019-07-03 | - | Kvartalsrapport 2019-Q3 |
| 2019-04-03 | - | Kvartalsrapport 2019-Q2 |
| 2019-01-17 | - | Kvartalsrapport 2019-Q1 |
| 2018-11-30 | - | X-dag ordinarie utdelning CHR 6.47 DKK |
| 2018-11-29 | - | Årsstämma |
| 2018-10-15 | - | Bokslutskommuniké 2018 |
| 2018-06-29 | - | X-dag bonusutdelning CHR 5.94 |
| 2018-06-28 | - | Kvartalsrapport 2018-Q3 |
| 2018-04-11 | - | Kvartalsrapport 2018-Q2 |
| 2018-01-12 | - | Kvartalsrapport 2018-Q1 |
| 2017-11-29 | - | Årsstämma |
| 2017-11-29 | - | X-dag ordinarie utdelning CHR 6.33 DKK |
| 2017-11-28 | - | Årsstämma |
| 2017-10-25 | - | Bokslutskommuniké 2017 |
| 2017-07-11 | - | X-dag bonusutdelning CHR 5.64 |
| 2017-07-05 | - | Kvartalsrapport 2017-Q3 |
| 2017-04-06 | - | Kvartalsrapport 2017-Q2 |
| 2017-01-11 | - | Kvartalsrapport 2017-Q1 |
| 2016-11-30 | - | X-dag ordinarie utdelning CHR 5.23 DKK |
| 2016-11-29 | - | Årsstämma |
| 2016-10-26 | - | Bokslutskommuniké 2016 |
| 2016-07-05 | - | Kvartalsrapport 2016-Q3 |
| 2016-04-07 | - | Kvartalsrapport 2016-Q2 |
| 2016-01-14 | - | Kvartalsrapport 2016-Q1 |
| 2015-11-27 | - | X-dag ordinarie utdelning CHR 4.70 DKK |
| 2015-11-26 | - | Årsstämma |
| 2015-10-21 | - | Bokslutskommuniké 2015 |
| 2015-07-07 | - | X-dag bonusutdelning CHR 6.57 |
| 2015-07-01 | - | Kvartalsrapport 2015-Q3 |
| 2015-04-09 | - | Kvartalsrapport 2015-Q2 |
| 2015-01-21 | - | Kvartalsrapport 2015-Q1 |
| 2014-11-28 | - | X-dag ordinarie utdelning CHR 3.77 DKK |
| 2014-11-27 | - | Årsstämma |
| 2014-10-22 | - | Bokslutskommuniké 2014 |
| 2014-07-02 | - | Kvartalsrapport 2014-Q3 |
| 2014-04-09 | - | Kvartalsrapport 2014-Q2 |
| 2014-01-15 | - | Kvartalsrapport 2014-Q1 |
| 2013-11-27 | - | X-dag ordinarie utdelning CHR 3.13 DKK |
| 2013-11-27 | - | X-dag bonusutdelning CHR 3.13 |
| 2013-11-26 | - | Årsstämma |
| 2013-10-23 | - | Bokslutskommuniké 2013 |
| 2013-07-03 | - | Kvartalsrapport 2013-Q3 |
| 2013-04-11 | - | Kvartalsrapport 2013-Q2 |
| 2013-01-16 | - | Kvartalsrapport 2013-Q1 |
| 2012-11-28 | - | X-dag ordinarie utdelning CHR 2.90 DKK |
| 2012-11-27 | - | Årsstämma |
| 2012-07-04 | - | Kvartalsrapport 2012-Q3 |
| 2012-04-19 | - | Kvartalsrapport 2012-Q2 |
| 2012-01-11 | - | Kvartalsrapport 2012-Q1 |
| 2011-11-30 | - | X-dag ordinarie utdelning CHR 3.57 DKK |
| 2011-11-29 | - | Årsstämma |
| 2011-07-06 | - | Kvartalsrapport 2011-Q3 |
| 2011-04-06 | - | Kvartalsrapport 2011-Q2 |
| 2011-01-12 | - | Kvartalsrapport 2011-Q1 |
| 2010-12-01 | - | X-dag ordinarie utdelning CHR 0.64 DKK |
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Large Cap Copenhagen |
| Sektor | Hälsovård |
| Industri | Bioteknik |
| NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART), IN OR INTO THE UNITED STATES, CANADA, SOUTH AFRICA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH ACTION WOULD BE UNLAWFUL. |
March 30, 2023
The proposed combination of Novozymes and Chr. Hansen has now been approved by each company’s respective shareholders, and with strong support from the shareholders the two biosolutions companies are now one step closer to uniting. The new company is expected to unleash the full potential of biological solutions and generate significant value for all stakeholders and society at large.
About Chr. Hansen
Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries. At Chr. Hansen, we are well positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends, we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world's most sustainable food ingredients company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.
About Novozymes
Novozymes is the world leader in biological solutions. Together with customers, partners, and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel, and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow.
Please see attachment.
Contact information
Investor Relations
Anders Mohr Christensen
+45 2515 2364
dkamc@chr-hansen.com
Press Relations
Sanne Seyer-Hansen
+45 6038 6207
dksash@chr-hansen.com